Zacks: Brokerages Expect LifePoint Health Inc (LPNT) Will Post Quarterly Sales of $1.56 Billion

Share on StockTwits

Wall Street brokerages expect that LifePoint Health Inc (NASDAQ:LPNT) will post sales of $1.56 billion for the current fiscal quarter, according to Zacks. Ten analysts have issued estimates for LifePoint Health’s earnings. The highest sales estimate is $1.59 billion and the lowest is $1.53 billion. LifePoint Health posted sales of $1.58 billion during the same quarter last year, which would indicate a negative year over year growth rate of 1.3%. The business is expected to issue its next quarterly earnings report on Friday, October 26th.

On average, analysts expect that LifePoint Health will report full year sales of $6.29 billion for the current fiscal year, with estimates ranging from $6.22 billion to $6.33 billion. For the next financial year, analysts expect that the firm will report sales of $6.44 billion per share, with estimates ranging from $6.38 billion to $6.53 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, July 27th. The company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.19. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The firm had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the firm posted $0.96 earnings per share. LifePoint Health’s revenue for the quarter was down 1.6% compared to the same quarter last year.

Several research analysts have commented on LPNT shares. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $55.00 price objective for the company in a research note on Wednesday, July 4th. BidaskClub lowered shares of LifePoint Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 26th. Mizuho set a $65.00 price objective on shares of LifePoint Health and gave the stock a “hold” rating in a research note on Monday, July 23rd. ValuEngine raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Tuesday, July 24th. Finally, William Blair reaffirmed a “hold” rating on shares of LifePoint Health in a research note on Friday, August 17th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $58.73.

Shares of LPNT stock traded up $0.10 on Friday, reaching $64.40. The company’s stock had a trading volume of 448,400 shares, compared to its average volume of 660,092. LifePoint Health has a 1 year low of $41.45 and a 1 year high of $65.35. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.63 and a current ratio of 1.85. The firm has a market cap of $2.49 billion, a PE ratio of 17.74, a price-to-earnings-growth ratio of 1.63 and a beta of 0.65.

Institutional investors and hedge funds have recently modified their holdings of the company. Point72 Asia Hong Kong Ltd boosted its stake in shares of LifePoint Health by 1,897.5% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock valued at $114,000 after purchasing an additional 2,296 shares during the period. Bank of Montreal Can purchased a new stake in shares of LifePoint Health during the second quarter valued at $169,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of LifePoint Health during the second quarter valued at $211,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of LifePoint Health during the second quarter valued at $219,000. Finally, Verition Fund Management LLC purchased a new stake in shares of LifePoint Health during the first quarter valued at $224,000.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Further Reading: Asset Allocation and Your Retirement

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply